Autor: |
Locatelli F; Department of Pediatric Hematology/Oncology and of Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Sapienza University of Rome, Rome, Italy. franco.locatelli@opbg.net., Whitlock JA; The Hospital for Sick Children/University of Toronto, Toronto, ON, Canada., Peters C; St. Anna Children's Hospital, Vienna, Austria., Chen-Santel C; Department of Paediatric Oncology/Hematology/BMT, Charité Universitäts Medizin Berlin, Berlin, Germany., Chia V; Amgen Inc, Thousand Oaks, CA, USA., Dennis RM; Nationwide Children's Hospital, The Ohio State University, Columbus, OH, USA., Heym KM; Cook Children's Medical Center, Fort Worth, TX, USA., Katz AJ; Amgen Inc, Thousand Oaks, CA, USA., Kelsh MA; Amgen Inc, Thousand Oaks, CA, USA.; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA., Sposto R; Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Tu H; Amgen Inc, Thousand Oaks, CA, USA., Tuglus CA; Amgen Inc, Thousand Oaks, CA, USA., Verma A; Primary Children's Hospital, Pediatric Hematology/Oncology, University of Utah, Salt Lake City, UT, USA., Vinti L; Department of Pediatric Hematology/Oncology and of Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Sapienza University of Rome, Rome, Italy., Wilkes JJ; Center for Clinical and Translational Research, Seattle Children's Hospital and Research Institute, Seattle, WA, USA.; Department of Pediatrics, University of Washington, Seattle, WA, USA., Zubarovskaja N; St. Anna Children's Hospital, Vienna, Austria., Zugmaier G; Amgen Research, Munich, Germany., von Stackelberg A; Department of Paediatric Oncology/Hematology/BMT, Charité Universitäts Medizin Berlin, Berlin, Germany., Sun W; City of Hope National Medical Center, Pediatric Hematology Oncology, Duarte, CA, USA.; Janssen Pharmaceutica, Beerse, Belgium. |